Skip to main content
Skip to content
Case File
efta-efta01521368DOJ Data Set 10Correspondence

EFTA Document EFTA01521368

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01521368
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL ACCT. For the Period 9/1/12 to 9/3W12 Equity Summary Asset Categories US Large Cap Equity 54,565.93 55,587.22 1,021.29 1% US Small/Mkt Cap Equity 8,280.00 5,130.00 (3,150.00) 1% Non-US Equity 130.35 139.76 9.41 1% Preferred Stocks 448,809.00 449,298.00 2,489.00 5% Concentrated 8 Other Equity 202.98000 206,825.00 3,839.00 3% Total Value 5712 771 28 $716,979.98 $4,208.70 11% Beginning Ending Change Current Asset Categories Market Value Market Value In Value Allocation Market Value/Cost Current Period Value Market Value 716,979.98 Tax Cost 764,967.39 Unrealized Gain/Loss (47,987.41) Estimated Annual Income 45,693.48 Accrued Dividends 6,048.36 Yield 6.35% Equity Detail Non -US Equity UsSrmItlitdCapEquoy US Lary Cap Equity Equity as a percentage of your portfolio - 11 % Preferred Stocks Concentrated 6 Other &way Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Dlv. Yield US Large Cap Equity APACHE CORP 037411-10-5 APA 86.47 95.000 8,214.65 11,403.30 (3,188.65) 64.60 0.79% JP Morgan Page 6 of 32 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048747 SDNY_GM_00317945 EFTA01521368

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.